Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Alcolea

Showing results (71-80 of 241) with videos related to

Pageof 25
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisPablo Zaragoza-Ballester, Briggitte Nuscher, Daniel Alcolea, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthMiguel A Santos-Santos, Stephanie M Grasso, Marco Calabria, et al.
Journal of Alzheimer'S Disease : JAD|December 20, 2015
Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative DementiasEstrella Morenas-Rodríguez, Laura Cervera-Carles, Eduard Vilaplana, et al.
Alzheimer'S Research & Therapy|October 3, 2020
Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individualsSylvain Lehmann, Julien Dumurgier, Xavier Ayrignac, et al.
Research Square|January 7, 2025
Impaired Cerebrospinal Fluid Lipoprotein-Mediated Cholesterol Delivery to Neurons in Alzheimer's DiseaseCarla Borràs, Marina Canyelles, David Santos, et al.
Annals of Clinical and Translational Neurology|August 30, 2019
Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on LumipulseDaniel Alcolea, Jordi Pegueroles, Laia Muñoz, et al.
Scientific Reports|May 26, 2019
Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's diseaseEstrella Morenas-Rodríguez, Daniel Alcolea, Marc Suárez-Calvet, et al.
Annals of Neurology|July 26, 2021
Metabolite Signature of Alzheimer's Disease in Adults with Down SyndromeVictor Montal, Isabel Barroeta, Alexandre Bejanin, et al.
Annals of Clinical and Translational Neurology|March 7, 2025
Relationship of cognitive decline with glucocerebrosidase activity and amyloid-beta 42 in DLB and PDMaria Camila Gonzalez, Linn Oftedal, Johannes Lange, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 3, 2020
Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological testsBessy Benejam, Laura Videla, Eduard Vilaplana, et al.
Pageof 25

Showing results (71-80 of 241) with videos related to

Sort By:
Pageof 25
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisPablo Zaragoza-Ballester, Briggitte Nuscher, Daniel Alcolea, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthMiguel A Santos-Santos, Stephanie M Grasso, Marco Calabria, et al.
Journal of Alzheimer'S Disease : JAD|December 20, 2015
Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative DementiasEstrella Morenas-Rodríguez, Laura Cervera-Carles, Eduard Vilaplana, et al.
Alzheimer'S Research & Therapy|October 3, 2020
Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individualsSylvain Lehmann, Julien Dumurgier, Xavier Ayrignac, et al.
Research Square|January 7, 2025
Impaired Cerebrospinal Fluid Lipoprotein-Mediated Cholesterol Delivery to Neurons in Alzheimer's DiseaseCarla Borràs, Marina Canyelles, David Santos, et al.
Annals of Clinical and Translational Neurology|August 30, 2019
Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on LumipulseDaniel Alcolea, Jordi Pegueroles, Laia Muñoz, et al.
Scientific Reports|May 26, 2019
Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's diseaseEstrella Morenas-Rodríguez, Daniel Alcolea, Marc Suárez-Calvet, et al.
Annals of Neurology|July 26, 2021
Metabolite Signature of Alzheimer's Disease in Adults with Down SyndromeVictor Montal, Isabel Barroeta, Alexandre Bejanin, et al.
Annals of Clinical and Translational Neurology|March 7, 2025
Relationship of cognitive decline with glucocerebrosidase activity and amyloid-beta 42 in DLB and PDMaria Camila Gonzalez, Linn Oftedal, Johannes Lange, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 3, 2020
Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological testsBessy Benejam, Laura Videla, Eduard Vilaplana, et al.
Pageof 25